J. Andrew Berglund, University of Oregon (IMAGE)

University of Oregon

J. Andrew Berglund, University of Oregon

Caption

Andrew Berglund, a member of the University of Oregon's Institute of Molecular Biology, studies myotonic dystrophy. His team has found an existing FDA-approved compound for a variety of diseases might be modified to treat RNA slicing defects that lead to the disease.

Credit

Photo by Jim Barlow

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.